Steroid-refractory PD-(L)1 pneumonitis: incidence, clinical features, treatment, and outcomes
Steroid-refractory PD-(L)1 pneumonitis: incidence, clinical features, treatment, and outcomes
About this item
Full title
Author / Creator
Publisher
England: BMJ Publishing Group Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: BMJ Publishing Group Ltd
Subjects
More information
Scope and Contents
Contents
BackgroundImmune-checkpoint inhibitor (ICI)-pneumonitis that does not improve or resolve with corticosteroids and requires additional immunosuppression is termed steroid-refractory ICI-pneumonitis. Herein, we report the clinical features, management and outcomes for patients treated with intravenous immunoglobulin (IVIG), infliximab, or the combina...
Alternative Titles
Full title
Steroid-refractory PD-(L)1 pneumonitis: incidence, clinical features, treatment, and outcomes
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_8744b96ba9a44fff9d9e0106c494995a
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_8744b96ba9a44fff9d9e0106c494995a
Other Identifiers
ISSN
2051-1426
E-ISSN
2051-1426
DOI
10.1136/jitc-2020-001731
